Structures by: Jeyaraman R.
Total: 25
N-Methyl-2,4-diphenyl-7-tertiary butyl 3-azabicyclo[3.3.1]nonane
C25H33N
Acta Crystallographica Section B (1999) 55, 5 793-798
a=13.6670(10)Å b=16.414(2)Å c=9.4090(10)Å
α=90.00° β=94.540(10)° γ=90.00°
N-Acetyl-2,4-diphenyl-3-azabicyclo[3.3.1]nonane
C22H25NO
Acta Crystallographica Section B (1999) 55, 5 793-798
a=14.6870(10)Å b=12.9310(10)Å c=18.5640(10)Å
α=90.00° β=90.00° γ=90.00°
N-Methyl-2,4-diorthomethyl phenyl-9-hydroxy 3-azabicyclo[3.3.1]nonane
C23H29NO
Acta Crystallographica Section B (1999) 55, 5 793-798
a=7.6380(10)Å b=13.1880(10)Å c=18.865(2)Å
α=90.00° β=97.940(10)° γ=90.00°
2,3,4,5-tetrahydro-r-2,c-4-diphenyl-1,5-benzothiazepine
C21H19NS
Acta Crystallographica Section E (2002) 58, 6 o701-o702
a=13.4782(15)Å b=6.0737(7)Å c=21.918(3)Å
α=90.00° β=107.327(3)° γ=90.00°
R-2,c-6-Di(p-tolyl)-t-3,t-5-dimethyltetrahydropyran-4-one
C21H24O2
Acta Crystallographica Section E (2003) 59, 4 o461-o462
a=9.0894(18)Å b=25.813(3)Å c=15.1605(10)Å
α=90.00° β=90.00° γ=90.00°
R-2,c-6-di(4-chlorophenyl)-t-3,t-5-dimethyltetrahydropyran-4-one
C19H18Cl2O2
Acta Crystallographica Section E (2003) 59, 4 o463-o465
a=15.0130(10)Å b=9.1230(16)Å c=25.462(4)Å
α=90.00° β=90.00° γ=90.00°
R-2,c-6-bis(4-chlorophenyl)-3,5-dimethyltetrahydropyran-t-4-ol
C19H20Cl2O2
Acta Crystallographica Section E (2003) 59, 2 o111-o113
a=12.1315(9)Å b=11.7075(19)Å c=26.177(3)Å
α=90° β=99.728(9)° γ=90°
2,6-dimethyl-3,5-(3-chlorophenyl)-4-formyl-cyclohexan-1-one
C21H20Cl2O2
Acta Crystallographica Section E (2002) 58, 10 o1053-o1054
a=7.635(2)Å b=12.1814(15)Å c=20.175(4)Å
α=90.00° β=90.00° γ=90.00°
4-Furoyl-2,3,4,5,6,7-hexahydro-r-2,c-7-diphenyl-1H-1,4-diazepin-5-one
C22H20N2O3
Acta Crystallographica Section E (2003) 59, 8 o1117-o1119
a=8.9941(2)Å b=19.8913(4)Å c=10.3244(2)Å
α=90.00° β=90.00° γ=90.00°
1-Benzyl-2-[(2RS,3SR,6SR)-3-methyl-4-oxo-2,6-diphenylpiperidin-1-ylcarbonyl]- 2-phenylethenyl phenylacetate
C42H37NO4
Acta Crystallographica Section E (2006) 62, 4 o1443-o1445
a=9.3027(3)Å b=12.1333(5)Å c=14.5927(6)Å
α=88.7510(17)° β=78.574(3)° γ=85.653(2)°
(2RS,3SR,6SR)-3-ethyl-2,6-diphenyl-1-phenylacetyl-4-piperidone
C27H27NO2
Acta Crystallographica Section E (2006) 62, 4 o1452-o1454
a=19.355(6)Å b=22.944(8)Å c=9.959(3)Å
α=90.00° β=97.905(6)° γ=90.00°
N(2)-Acetyl-1,3-diphenyl-1,2,3,4-tetrahydrobenzo[b]-1,6-naphthyridine
C26H22N2O
Acta Crystallographica Section E (2001) 57, 7 o599-o601
a=10.394(2)Å b=10.493(3)Å c=20.265(4)Å
α=76.03(2)° β=79.83(2)° γ=72.21(2)°
N-ethoxycarbonyl-3,5-dimethyl-cis-2,6-diphenyl piperidin-4-one
C22H25NO3
Acta Crystallographica Section C (1998) 54, 6 870-872
a=10.404(2)Å b=9.743(2)Å c=19.096(3)Å
α=90.00° β=95.70(2)° γ=90.00°
C17H17N3O2
C17H17N3O2
Acta Crystallographica Section C (1992) 48, 6 1048-1051
a=7.6590(10)Å b=12.7410(10)Å c=15.0950(10)Å
α=90° β=90° γ=90°
C20H24N2O1
C20H24N2O1
Acta Crystallographica Section C (1994) 50, 5 827-829
a=5.903(2)Å b=11.143(5)Å c=13.912(4)Å
α=77.72(3)° β=82.83(2)° γ=83.12(3)°
C20H22N2O
C20H22N2O
Acta Crystallographica Section C (1993) 49, 8 1519-1522
a=18.456(2)Å b=24.097(3)Å c=7.5400(10)Å
α=90.0° β=91.80(10)° γ=90.0°
C22H24N2O4
C22H24N2O4
Acta Crystallographica Section C (1993) 49, 5 983-985
a=7.5210(10)Å b=10.872(2)Å c=22.901(3)Å
α=90° β=90° γ=90°
1-acetyltetrahydro-4-methyl-2,4-diphenyl-5H-1,5-benzodiazepine
C24H24N2O
Acta Crystallographica Section C (1999) 55, 8 1355-1357
a=20.9990(10)Å b=14.3970(5)Å c=12.648(4)Å
α=90.00° β=90.00° γ=90.00°
2-Nitroso-1,3-diphenyl-1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine
C24H19N3O
Acta Crystallographica Section C (2003) 59, 3 o153-o155
a=9.713(6)Å b=19.265(8)Å c=10.450(2)Å
α=90° β=105.74(3)° γ=90°
(2RS,6SR)-N-diphenylacetyl-2,6-diphenyl-4-piperidone
C31H27NO2
Acta Crystallographica Section C (2006) 62, 6 o324-o327
a=11.2499(2)Å b=11.8622(3)Å c=18.2320(5)Å
α=90.00° β=107.8750(15)° γ=90.00°
(2RS,3SR,5RS,6SR)-3,5-dimethyl-N-phenylacetyl-2,6-diphenyl-4-piperidinone
C27H27NO2
Acta Crystallographica Section C (2006) 62, 6 o324-o327
a=9.9503(4)Å b=11.8623(6)Å c=18.5654(8)Å
α=77.920(2)° β=84.699(3)° γ=85.731(2)°
N-Benzoyl-<i>r</i>-2,<i>c</i>-4,<i>t</i>-6,<i>t</i>-8- tetraphenyl-3-thia-7-azabicyclo[3.3.1]nonane
C38H33NOS
Acta Crystallographica Section C (2010) 66, 8 o396-o400
a=16.139(5)Å b=10.145(5)Å c=17.453(5)Å
α=90° β=92.046(5)° γ=90°
N-Phenylacetyl-<i>r</i>-2,<i>c</i>-4,<i>t</i>-6,<i>t</i>-8\ -tetraphenyl-3-thia-7-azabicyclo[3.3.1]nonane
C39H35NOS
Acta Crystallographica Section C (2010) 66, 8 o396-o400
a=16.8724(7)Å b=9.4863(3)Å c=19.2376(8)Å
α=90° β=93.2450(10)° γ=90°
2,4-o-tolyl-3-azabicyclo[3.3.1]nonan-9-one
C22H25NO
Acta Crystallographica Section C (2000) 56, 10 1240-1241
a=7.692(3)Å b=16.825(3)Å c=13.7247(18)Å
α=90.00° β=99.428(18)° γ=90.00°
C12H16N2OS
C12H16N2OS
Zeitschrift für Kristallographie - New Crystal Structures (2002) 217, 4 605-606
a=31.342(5)Å b=6.9265(13)Å c=12.322(2)Å
α=90.000(4)° β=110.741(4)° γ=90.000(4)°